Take Solutions: Smallcap stock surged 22% in a week; know details
Small cap stocks entail big risk but also embody the possibility of big gains, provided they are carefully picked. Take Solutions is a penny stock which is trading below Rs 30 but rising a jet speed.
Kolkata: Take Solutions is a full-service contract research organisation. It offers services for the pharmaceuticals, biotech and devices companies across the world. The bedrock of business is modern technology and skills of its employees. The range of services span from clinical trials to regulatory submissions to post-marketing safety. The customers of the company feature large and small innovator biopharmaceutical and devices companies and also manufacturers of generics.
It is a penny stock that is rising at jet speed. On Nov 14 in the early session of trade, Take Solutions stocks were trading at Rs 28.83, up Rs 1.37 or 4.99%. In the past five days, it rose 21.44% and 62.24% in the past one month. The stock also hit the upper circuit on Nov 13. What's triggering this surge? It appears that Q2FY26 financial results provided the shot in the arm for the stock. The market cap of the stock was at Rs 426.49 crore on Nov 14 morning. It hit the upper circuit of Rs 27.46 on Nov 13, when it rose from its previous closing price of Rs 26.16. Let's have a look.
Q2FY26 financial performance
The company's Q2 results were announced on October 27, 2025. The company reported a consolidated net profit of Rs 6.29 crore in Q2 FY26, a significant turnaround from a net loss of Rs 1.58 crore in the same quarter a year ago. The profit is primarily driven by its earnings from the discontinued operations of its 100% subsidiary, Ecron Acunova. The ROCE and ROE of Take Solutions are 21.32% and 15.55% respectively. The company's EPS is Rs 0.27 and the company has not debts in its books, which boosts confidence of the investors.
Founded in 2000, Take Solutions is a global technology company providing end-to-end services in the life sciences and supply chain management sectors. The company provides clinical research, generics support, regulatory filings, pharmacovigilance, and supply chain automation. Its client list includes global pharmaceutical, biotech, medical device, and generic companies. Its operations are spread all over India, the US countries in Europe as well as other parts of the globe.
Disclaimer: This article is only meant to provide information. TV9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, REITs, INVITs, any form of alternative investment instruments and crypto assets.